Author

Seyed Mohammadreza Hashemian

CRDRC, NRITLD,SBMU - Cited by 9,292 - Critical Care Medicine

Biography

Dr. Seyed Mohammadreza Hashemian  is working in Department of Critical Care Medicine, National Research Institute of Tuberculosis and Lung Disease (NRITLD) Located at Iran. Currently , Dr. Seyed Mohammadreza Hashemian is the author/editors/reviewer in several international journals. He published 5 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
SMR Hashemian, R Aliannejad, M Zarrabi, M Soleimani, M Vosough, ...Stem cell research & therapy 12 (1), 1-12, 2021202
139
2021
Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study
SO Labeau, E Afonso, J Benbenishty, B Blackwood, C Boulanger, SJ Brett, ...Intensive Care Medicine 47 (4), 503-520, 2021202
135
2021
Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19
M Teymouri, S Mollazadeh, H Mortazavi, ZN Ghale-Noie, V Keyvani, ...Pathology-Research and Practice 221, 153443, 2021202
77
2021
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial
H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ...European Journal of Pharmacology 897, 173947, 2021202
69
2021
Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients
E Mortaz, P Tabarsi, H Jamaati, N Dalil Roofchayee, NK Dezfuli, ...Frontiers in Immunology 12, 592727, 2021202
55
2021
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
MV Maddali, M Churpek, T Pham, E Rezoagli, H Zhuo, W Zhao, J He, ...The Lancet Respiratory Medicine 10 (4), 367-377, 2022202
45
2022
RdRp inhibitors and COVID-19: Is molnupiravir a good option?
SMR Hashemian, MH Pourhanifeh, MR Hamblin, MK Shahrzad, H MirzaeiBiomedicine & Pharmacotherapy 146, 112517, 2022202
44
2022
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
SMR Hashemian, N Shafigh, G Afzal, H Jamaati, P Tabarsi, M Marjani, ...Pulmonology 27 (6), 486-492, 2021202
41
2021
A review on favipiravir: the properties, function, and usefulness to treat COVID-19
SMR Hashemian, T Farhadi, AA VelayatiExpert review of anti-infective therapy 19 (8), 1029-1037, 2021202
38
2021
Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study
T Pham, A Pesenti, G Bellani, G Rubenfeld, E Fan, G Bugedo, JA Lorente, ...European Respiratory Journal 57 (6), 2021202
33
2021
Epidemiological characteristics, ventilator management, and clinical outcome in patients receiving invasive ventilation in intensive care units from 10 Asian middle-income …
L Pisani, AG Algera, AS Neto, A Ahsan, A Beane, K Chittawatanarat, ...The American journal of tropical medicine and hygiene 104 (3), 1022, 212
20
2021
Dapsone ameliorates colitis through TLR4/NF-kB pathway in TNBS induced colitis model in rat
RM Jafari, S Shayesteh, M Ala, H Yousefi-Manesh, A Rashidian, ...Archives of medical research 52 (6), 595-602, 2021202
16
2021
Cytokines and microRNAs in SARS-CoV-2: What do we know?
FZ Rarani, B Rashidi, MHJN Abadi, MR Hamblin, SMR Hashemian, ...Molecular Therapy-Nucleic Acids, 2022202
12
2022
Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
E Roshandel, G Sankanian, M Salimi, A Jalili, S Salari, A Sadeghi, ...Transfusion and Apheresis Science 60 (4), 3141, 2021202
10
2021
Death in hospital following ICU discharge: insights from the LUNG SAFE study
F Madotto, B McNicholas, E Rezoagli, T Pham, JG Laffey, G Bellani, ...Critical Care 25, 1-17, 2021202
10
2021
Mechanical ventilation discontinuation practices in Asia: a multinational survey
CHC Leung, A Lee, YM Arabi, J Phua, JV Divatia, Y Koh, B Du, CC Tan, ...Annals of the American Thoracic Society 18 (8), 1352-135, 2021202
9
2021
photobiomodulation improves serum cytokine response in mild to moderate Covid-19:The first Randomized ,Double-Blind,Placebo Controlled,a pilot study
photobiomodulation improves serum cytokine response in mild to moderate Covid-1:The first Randomized ,Double-Blind,Placebo Controlled,a pilot studyseyed mehran marashian,mohammadreza Hashemianfrontiers in immunology 13, 2022202
9
2022
Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?
Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-1 antigens?D Hassani, MM Amiri, F Maghsood, V Salimi, GA Kardar, O Barati, ...Iranian Journal of Immunology 18 (1), 47-53, 2021202
9
2021
The story of critical care in Asia: a narrative review
J Phua, CM Lim, MO Faruq, KMK Nafees, B Du, CD Gomersall, L Ling, ...Journal of intensive care 9 (1), 1-12, 2021202
7
2021
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study
T Pham, L Heunks, G Bellani, F Madotto, I Aragao, G Beduneau, ...The Lancet Respiratory Medicine 11 (5), 465-46, 2023202
7
2023

Referred From: https://scholar.google.com/citations?user=2OuATjsAAAAJ&hl=en

Cited by
Citations 9292
h-index 37
i10-index 97
Recommended Journals
Open Access Journals